Skip to content

Individualised patient care and treatment for maternal diabetes

Understanding the glycaemic profile of maternal diabetes using continuous glucose monitoring: intensive glucose profiling to inform patient care and treatment (INFORMED)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57579163
Enrollment
76
Registered
2022-02-25
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

This study aims to determine if diet is an effective way to manage glucose levels during pregnancy in a diverse population of pregnant women with diabetes. To investigate this, the researchers will re
(ii) offer researchers access to their clinical urine sample for analysis
(iii) provide an additional blood sample (10 ml) at three clinical visits
and (iv) to perform specific tasks in their own home related to diet and physical activity that they are comfortable with (outlined below). Study design: This study ha
and 2) an optional nested cross-over dietary intervention study to compare two specially designed meals, that differ in carbohydrate quality, to evaluate the effect of carbohydrate quality on CGM gluc

Sponsors

University of Leeds
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 18-45 years 2. Singleton pregnancy 3. Pregnant women in the first trimester of pregnancy 4. Diagnosed with either type 1 or type 2 diabetes mellitus

Exclusion criteria

Exclusion criteria: 1. Women aged under 18 or above 45 years 2. Women presenting after 14 weeks gestation 3. Multiple pregnancy 4. Foetal congenital abnormality 5. No diagnosis of diabetes 6. Diagnosis of gestational diabetes 7. Significant co-existent medical condition (e.g. overt diabetes complications, cancer, gut mobility or digestion disorder) 8. Significant psychological (e.g. anorexia, bulimia) and/or mental disorders which undermines informed consent 9. Dietary allergies or intolerance (for the standardised meals 10. Lack of internet access on a computer or tablet at home 11. Unable to understand written English and provide informed consent

Design outcomes

Primary

MeasureTime frame
Measures of (dys)glycaemia (e.g. CGM data, HbA1c) accessed at approximately 10-12, 18-20, and 28-34 weeks' gestation

Secondary

MeasureTime frame
1. Medical details of health, pregnancy, and delivery collected via routine care at the diabetes in pregnancy clinic at Leeds Teaching Hospitals NHS Trust on three occasions at ~10-12, 18-20, and 28-34 weeks of gestation 2. Lifestyle information: 2.1. Maternal dietary intake recorded using the myFood24 app over 3 days (2 weekdays and 1 weekend) 2.2. Physical activity and sleep recorded using Pregnancy Physical Activity Questionnaire (PPAQ) and Leeds Sleep Evaluation Questionnaire (LSEQ) questionnaires, respectively, on three occasions at ~10-12, 18-20, and 28-34 weeks of gestation 3. Metabolomics and genetic analysis using urine and blood samples on three occasions at ~10-12, 18-20, and 28-34 weeks of gestation

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 10, 2026